ASRC Press Releases

NAD Finds General Mills Can Support Certain Yoplait ‘Greek’ Yogurt Taste-Test Claims, but Recommends Advertiser Modify or Discontinue Certain Comparative Claims Against Chobani

NAD has determined that General Mills, Inc., can support certain claims made for its Yoplait “Greek” yogurt in online advertising and social media, but recommended the advertiser discontinue or modify certain claims. The claims at issue were challenged by Chobani, Inc.

Read More

NAD Recommends Nurture Modify, Discontinue Certain Claims for ‘Happy Family’ Baby Food; Finds Advertiser Can Support Certain ‘Organic’ Claims

NAD has recommended that Nurture, Inc., the maker of Happy Family infant and toddler food products, modify or discontinue certain claims, including claims that state or imply that conventional or non-organic products are less nutritious, expose babies and toddlers to pesticides or contain genetically modified organisms (GMOs.) NAD did find, however, that the advertiser could continue its “organic superfoods,” “organic baby food,” and “always organic” claims.

Read More

NAD Refers Advertising for MiMedx Wound-Care Products to FDA, FTC for Further Review

NAD has referred advertising claims made by MiMedx Group, Inc., for its EpiFix and EpiFix Micronized wound-care products to the FTC and FDA for further review, after the advertiser declined to participate in NAD’s review of its advertising claims.

Read More

NAD Reviews Taboola’s Native Ad Widget, Recommends Clearer Disclosures

NAD has recommended that Taboola LCC, modify its native advertising “recommendation widget” to better assure that consumers understand that clicking on links provided by Taboola will take them to “sponsored content.”

Read More

NAD Recommends Akeso Discontinue Multiple Claims for MigreLief Products, Finds Company can Support Certain Ingredients Claims

NAD has recommended that Akeso, LLC, the maker of “MigreLief Original Formula” for adults and “Children’s Migrelief” dietary supplements, discontinue a wide range of claims for the products, which are marketed as providing relief from migraine headaches.

Read More

NAD Recommends Mars Petcare Discontinue Certain Claims for ‘Dentastix’ Following Purina

NAD has recommended that Mars Petcare US discontinue certain express and implied claims made for the company’s Pedigree Dentastix dog chews. The claims at issue, made in print, Internet and social media advertising and on product packaging, were challenged by Nestle Purina Petcare Company, a competing maker of pet products.

Read More